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Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. 
Unresectable HCC’s are currently treated using local injections of chemotherapeutics or radioactive 
particles during transarterial liver catheterization. This strategy may increase local drug 
concentrations near tumorous tissue, while limiting the systemic toxicity compared to conventional 
chemotherapy. Though promising, the optimal treatment conditions (injection location, dose...) are 
still unknown. As the vasculature feeding the tumor plays a key role, this study focuses on exploring 
the added value of computational models to optimize targeted drug delivery for HCC. 
Methods: 
A patient-specific hepatic arterial geometry was obtained from micro-CT data of a human liver [1]. 
The 3D reconstruction was truncated at the 4th blood vessel generation and an inflow extension was 
added (Fig. 1a). The volume mesh counted 8.9 million elements. Computational fluid dynamics 
calculations were performed using Fluent (Ansys, USA) to simulate both the blood flow (continuous 
shear-thinning fluid phase; viscosities estimated using Quemada model) and drug transport (discrete 
phase) in the liver. Particle tracking allowed calculating the trajectories of individual drug carriers 
through the flow field. Baseline boundary conditions included a velocity inlet of 0.155 m/s at the 
hepatic artery, while the outlet flow distribution was estimated using Murray’s law. Particles were 
released using a uniform surface injection of 104 particles. A sensitivity study was performed to study 
the impact of relevant parameters (injection velocity, particle size…) on the particle distribution. 
Results and discussion: 
The results were analyzed using particle release maps of the injection plane (Fig. 1b), in which each 
color represents the injection locations to target one specific outlet. Results showed that the cross-
sectional injection location has a huge impact on the particle distribution, as also found in [3]. A good 
choice of this parameter may allow targeting a specific outlet (Fig. 1b-c). Other parameters having a 
significant impact on the particle distribution, are the position of the injection plane (Fig. 1c; proximal 
versus distal placement of the catheter), the particle density (1600-3600 kg/m³), and the particle 
diameter (40-100 µm), leading to changes in the outlet-specific number of exiting particles up to ± 
64%, 61%, and 79%, respectively. In contrast, variations of the injection velocity (0.1-0.2 m/s) had 
only little impact (up to ± 6%). 
This feasibility study indicates the potential of patient-specific computational models to optimize 
targeted drug delivery for liver cancer [2]. Future work will focus on validating the numerical 
modelling approach and testing it in a cohort of HCC patients that received transarterial therapy. 
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Figure 1. Preliminary results on modelling the drug particle transport in a human liver: (a) patient-specific geometry of a hepatic arterial 
vascular tree; (b) particle release map of the injection plane in which each color represents the injection locations targeting one specific 
outlet; (c) example of targeting a specific outlet when injecting at the location indicated by the box in panel b. 
